Beam Therapeutics publishes sickle cell therapy data in medical journal

April 1, 2026 5:12 PM

Beam Therapeutics Inc. (NASDAQ: BEAM) announced the publication of Phase 1/2 clinical trial data for its experimental sickle cell disease ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found